投资公司在收入丰厚、红利增加之后,刺激了Eli Lilly的股份。 Investment firms boost Eli Lilly holdings after strong earnings and increased dividend.

一些投资公司增加了在Eli Lilly和一家制药公司公司Eli Lilly的股份,Haverford Trust公司和APG资产管理公司N.V.Eli Lilly的显著采购表明,其收益和收入丰厚,超过分析师的预期,并将2025财政年度指导定为21.750-23.000 EPS。 Several investment firms have increased their holdings in Eli Lilly and Company, a pharmaceutical firm, with notable purchases by Haverford Trust Co and APG Asset Management N.V. Eli Lilly reported strong earnings and revenue, surpassing analyst expectations, and set FY 2025 guidance at 21.750-23.000 EPS. 该公司还宣布每季度每股1.50美元的股利。 The company also announced a quarterly dividend of $1.50 per share. 分析家预测本财政年度的EPS为23.48。 Analysts predict 23.48 EPS for the current fiscal year.